ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Position in AXGN — Axogen, Inc.

CIK 1164508 BOSTON, MA

Position in AXGN

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$8,590,509

-$14,640,295 QoQ

Shares Held

259,297

-63.5% QoQ

Ownership

0.488%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

9 quarters on record

Voting authority Sole 99.32895482786148.ToString("F0")% Shared 0.ToString("F0")% None 0.671045172138513.ToString("F0")%

Healthcare · as of Mar 31, 2026

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $3,649,670,055 across 35 Medical Devices names. AXGN ranks #20 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BSX	Boston Scientific Corp	13,891,668	$871,702,167
2	ABT	Abbott Laboratories	5,522,222	$566,966,532
3	SYK	Stryker Corp	1,555,638	$511,167,090
4	MDT	Medtronic plc	4,659,425	$403,739,176
5	PODD	Insulet Corp	1,229,928	$258,088,091
6	DXCM	Dexcom Inc	2,545,103	$159,832,468
7	EW	Edwards Lifesciences Corp	1,890,859	$151,419,988
8	PEN	Penumbra Inc	400,160	$131,400,539

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,590,509	259,297	-63.5%	Shares	Defined	2026-05-14
2025-12-31	$23,230,804	709,771	+45.2%	Shares	Defined	2026-02-13
2025-09-30	$8,720,709	488,829	+1578.6%	Shares	Defined	2025-11-13
2025-06-30	$315,973	29,122	-70.1%	Shares	Defined	2025-08-13
2025-03-31	$1,799,865	97,290	0.0%	Shares	Defined	2025-05-14
2024-12-31	$1,603,339	97,290	+37.0%	Shares	Defined	2025-02-12
2024-09-30	$995,307	70,992	+305.2%	Shares	Defined	2024-11-14
2024-03-31	$141,402	17,522	-67.0%	Shares	Defined	2024-05-15
2023-12-31	$362,625	53,093	—	Shares	Defined	2024-02-14
No filing history on record for this holder in this stock.